Interim report January – June 2023 for CombiGene AB (publ)
August 25, 2023
April – June 2023• Net sales: TSEK 1,788 (4,738).• Other operating revenues: TSEK 1,413 (9,800).• Profit
April – June 2023• Net sales: TSEK 1,788 (4,738).• Other operating revenues: TSEK 1,413 (9,800).• Profit
The following resolutions were passed at the annual general meeting (the “AGM”) of CombiGene AB (publ)
January – March 2023• Net sales: TSEK 2,168 (11,403).• Other operating revenues: TSEK 0 (2,801).• Profit
CombiGene announces that the annual report now is available on the Company´s homepage, www.combigene.com, and as
The shareholders of CombiGene AB (publ) reg. no. 556403-3818 (the “Company”) are hereby summoned to attend
October – December 2022• Net sales: TSEK 5,346 (84,042).• Other operating revenues: TSEK 674 (1,098).• Profit
October – December 2022• Net sales: TSEK 5,346 (84,042).• Other operating revenues: TSEK 674 (1,098).• Profit
July – September 2022• Net sales: 5,213 (0) TSEK.• Other operating revenues: 8,313 (423) TSEK.• Profit
The nominating committee has been constituted in accordance with the resolution adopted by the annual general
STOCKHOLM — On September 27, 2022, CombiGene ("CombiGene", the "Company") announced that Peter Ekolind joins the